 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1htj
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
1 term
|
 |
|
Biological process
|
termination of G-protein coupled receptor signaling pathway
|
1 term
|
 |
|
Biochemical function
|
Rho guanyl-nucleotide exchange factor activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
9:559-569
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the RGS-like domain from PDZ-RhoGEF: linking heterotrimeric g protein-coupled signaling to Rho GTPases.
|
|
K.L.Longenecker,
M.E.Lewis,
H.Chikumi,
J.S.Gutkind,
Z.S.Derewenda.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: The multidomain PDZ-RhoGEF is one of many known guanine nucleotide
exchange factors that upregulate Rho GTPases. PDZ-RhoGEF and related family
members play a critical role in a molecular signaling pathway from
heterotrimeric G protein-coupled receptors to Rho proteins. A approximately 200
residue RGS-like (RGSL) domain in PDZ-RhoGEF and its homologs is responsible for
the direct association with Galpha12/13 proteins. To better understand
structure-function relationships, we initiated crystallographic studies of the
RGSL domain from human PDZ-RhoGEF. RESULTS: A recombinant construct of the RGSL
domain was expressed in Escherichia coli and purified, but it did not
crystallize. Alternative constructs were designed based on a novel strategy of
targeting lysine and glutamic acid residues for mutagenesis to alanine. A
triple-point mutant functionally identical to the wild-type protein was
crystallized, and its structure was determined by the MAD method using
Se-methionine (Se-Met) incorporation. A molecular model of the RGSL domain was
refined at 2.2 A resolution, revealing an all-helical tertiary fold with the
mutations located at intermolecular lattice contacts. CONCLUSIONS: The first
nine helices adopt a fold similar to that observed for RGS proteins, although
the sequence identity with other such known structures is below 20%. The last
three helices are an integral extension of the RGS fold, packing tightly against
helices 3 and 4 with multiple hydrophobic interactions. Comparison with RGS
proteins suggests features that are likely relevant for interaction with G
proteins. Finally, we conclude that the strategy used to produce crystals was
beneficial and might be applicable to other proteins resistant to
crystallization.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 4.
Figure 4. Tertiary Fold of the RGSL Domain(a) This ribbon
diagram is colored from the N terminus (red) to the C terminus
(blue), and secondary structural elements are numbered
sequentially.(b) Alignment of the RGSL domain and the structure
of RGS4 (gray) is shown in stereo as an a-carbon trace from the
same perspective as in (a). The RGSL is colored green for the
overlapping portion and colored magenta for the C-terminal
extension. The residue numbering of the RGSL domain is labeled
according to the full-length PDZ-RhoGEF 
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2001,
9,
559-569)
copyright 2001.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Aittaleb,
C.A.Boguth,
and
J.J.Tesmer
(2010).
Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors.
|
| |
Mol Pharmacol, 77,
111-125.
|
 |
|
|
|
|
 |
Z.S.Derewenda
(2010).
Application of protein engineering to enhance crystallizability and improve crystal properties.
|
| |
Acta Crystallogr D Biol Crystallogr, 66,
604-615.
|
 |
|
|
|
|
 |
M.Zheng,
T.Cierpicki,
K.Momotani,
M.V.Artamonov,
U.Derewenda,
J.H.Bushweller,
A.V.Somlyo,
and
Z.S.Derewenda
(2009).
On the mechanism of autoinhibition of the RhoA-specific nucleotide exchange factor PDZRhoGEF.
|
| |
BMC Struct Biol, 9,
36.
|
 |
|
|
|
|
 |
N.Suzuki,
N.Hajicek,
and
T.Kozasa
(2009).
Regulation and physiological functions of G12/13-mediated signaling pathways.
|
| |
Neurosignals, 17,
55-70.
|
 |
|
|
|
|
 |
Z.Chen,
W.D.Singer,
S.M.Danesh,
P.C.Sternweis,
and
S.R.Sprang
(2008).
Recognition of the activated states of Galpha13 by the rgRGS domain of PDZRhoGEF.
|
| |
Structure, 16,
1532-1543.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.R.Cooper,
T.Boczek,
K.Grelewska,
M.Pinkowska,
M.Sikorska,
M.Zawadzki,
and
Z.Derewenda
(2007).
Protein crystallization by surface entropy reduction: optimization of the SER strategy.
|
| |
Acta Crystallogr D Biol Crystallogr, 63,
636-645.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Goldschmidt,
D.R.Cooper,
Z.S.Derewenda,
and
D.Eisenberg
(2007).
Toward rational protein crystallization: A Web server for the design of crystallizable protein variants.
|
| |
Protein Sci, 16,
1569-1576.
|
 |
|
|
|
|
 |
M.Salomone-Stagni,
B.Zambelli,
F.Musiani,
and
S.Ciurli
(2007).
A model-based proposal for the role of UreF as a GTPase-activating protein in the urease active site biosynthesis.
|
| |
Proteins, 68,
749-761.
|
 |
|
|
|
|
 |
G.B.Willars
(2006).
Mammalian RGS proteins: multifunctional regulators of cellular signalling.
|
| |
Semin Cell Dev Biol, 17,
363-376.
|
 |
|
|
|
|
 |
M.V.Lasker,
S.M.Kuruvilla,
M.M.Gajjar,
A.Kapoor,
and
S.K.Nair
(2006).
Metal ion-mediated reduction in surface entropy improves diffraction quality of crystals of the IRAK-4 death domain.
|
| |
J Biomol Tech, 17,
114-121.
|
 |
|
|
|
|
 |
U.Herbrand,
and
M.R.Ahmadian
(2006).
p190-RhoGAP as an integral component of the Tiam1/Rac1-induced downregulation of Rho.
|
| |
Biol Chem, 387,
311-317.
|
 |
|
|
|
|
 |
Z.S.Derewenda,
and
P.G.Vekilov
(2006).
Entropy and surface engineering in protein crystallization.
|
| |
Acta Crystallogr D Biol Crystallogr, 62,
116-124.
|
 |
|
|
|
|
 |
C.R.McCudden,
M.D.Hains,
R.J.Kimple,
D.P.Siderovski,
and
F.S.Willard
(2005).
G-protein signaling: back to the future.
|
| |
Cell Mol Life Sci, 62,
551-577.
|
 |
|
|
|
|
 |
D.M.Anstrom,
L.Colip,
B.Moshofsky,
E.Hatcher,
and
S.J.Remington
(2005).
Systematic replacement of lysine with glutamine and alanine in Escherichia coli malate synthase G: effect on crystallization.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 61,
1069-1074.
|
 |
|
|
|
|
 |
J.Garzón,
M.Rodríguez-Muñoz,
E.de la Torre-Madrid,
and
P.Sánchez-Blázquez
(2005).
Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.
|
| |
Psychopharmacology (Berl), 180,
1.
|
 |
|
|
|
|
 |
Z.Chen,
W.D.Singer,
P.C.Sternweis,
and
S.R.Sprang
(2005).
Structure of the p115RhoGEF rgRGS domain-Galpha13/i1 chimera complex suggests convergent evolution of a GTPase activator.
|
| |
Nat Struct Mol Biol, 12,
191-197.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Oleksy,
H.Barton,
Y.Devedjiev,
M.Purdy,
U.Derewenda,
J.Otlewski,
and
Z.S.Derewenda
(2004).
Preliminary crystallographic analysis of the complex of the human GTPase RhoA with the DH/PH tandem of PDZ-RhoGEF.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
740-742.
|
 |
|
|
|
|
 |
I.Janda,
Y.Devedjiev,
D.Cooper,
M.Chruszcz,
U.Derewenda,
A.Gabrys,
W.Minor,
A.Joachimiak,
and
Z.S.Derewenda
(2004).
Harvesting the high-hanging fruit: the structure of the YdeN gene product from Bacillus subtilis at 1.8 angstroms resolution.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
1101-1107.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Banerjee,
and
P.B.Wedegaertner
(2004).
Identification of a novel sequence in PDZ-RhoGEF that mediates interaction with the actin cytoskeleton.
|
| |
Mol Biol Cell, 15,
1760-1775.
|
 |
|
|
|
|
 |
J.Czepas,
Y.Devedjiev,
D.Krowarsch,
U.Derewenda,
J.Otlewski,
and
Z.S.Derewenda
(2004).
The impact of Lys-->Arg surface mutations on the crystallization of the globular domain of RhoGDI.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
275-280.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.P.Doye,
A.A.Louis,
and
M.Vendruscolo
(2004).
Inhibition of protein crystallization by evolutionary negative design.
|
| |
Phys Biol, 1,
P9-13.
|
 |
|
|
|
|
 |
P.W.Day,
J.J.Tesmer,
R.Sterne-Marr,
L.C.Freeman,
J.L.Benovic,
and
P.B.Wedegaertner
(2004).
Characterization of the GRK2 binding site of Galphaq.
|
| |
J Biol Chem, 279,
53643-53652.
|
 |
|
|
|
|
 |
U.Derewenda,
A.Mateja,
Y.Devedjiev,
K.M.Routzahn,
A.G.Evdokimov,
Z.S.Derewenda,
and
D.S.Waugh
(2004).
The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague.
|
| |
Structure, 12,
301-306.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.S.Derewenda
(2004).
Rational protein crystallization by mutational surface engineering.
|
| |
Structure, 12,
529-535.
|
 |
|
|
|
|
 |
D.T.Lodowski,
J.A.Pitcher,
W.D.Capel,
R.J.Lefkowitz,
and
J.J.Tesmer
(2003).
Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma.
|
| |
Science, 300,
1256-1262.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Sterne-Marr,
J.J.Tesmer,
P.W.Day,
R.P.Stracquatanio,
J.A.Cilente,
K.E.O'Connor,
A.N.Pronin,
J.L.Benovic,
and
P.B.Wedegaertner
(2003).
G protein-coupled receptor Kinase 2/G alpha q/11 interaction. A novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits.
|
| |
J Biol Chem, 278,
6050-6058.
|
 |
|
|
|
|
 |
T.Wieland,
and
C.Mittmann
(2003).
Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system.
|
| |
Pharmacol Ther, 97,
95.
|
 |
|
|
|
|
 |
Z.Chen,
W.D.Singer,
C.D.Wells,
S.R.Sprang,
and
P.C.Sternweis
(2003).
Mapping the Galpha13 binding interface of the rgRGS domain of p115RhoGEF.
|
| |
J Biol Chem, 278,
9912-9919.
|
 |
|
|
|
|
 |
A.Mateja,
Y.Devedjiev,
D.Krowarsch,
K.Longenecker,
Z.Dauter,
J.Otlewski,
and
Z.S.Derewenda
(2002).
The impact of Glu-->Ala and Glu-->Asp mutations on the crystallization properties of RhoGDI: the structure of RhoGDI at 1.3 A resolution.
|
| |
Acta Crystallogr D Biol Crystallogr, 58,
1983-1991.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.N.Johnson,
and
K.M.Druey
(2002).
Functional characterization of the G protein regulator RGS13.
|
| |
J Biol Chem, 277,
16768-16774.
|
 |
|
|
|
|
 |
H.Chikumi,
S.Fukuhara,
and
J.S.Gutkind
(2002).
Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of a role for focal adhesion kinase.
|
| |
J Biol Chem, 277,
12463-12473.
|
 |
|
|
|
|
 |
R.R.Neubig,
and
D.P.Siderovski
(2002).
Regulators of G-protein signalling as new central nervous system drug targets.
|
| |
Nat Rev Drug Discov, 1,
187-197.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|